Skip to content
← Back to this collection

PUBLICATIONS · 12180489

Alemtuzumab in T-cell malignancies.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Med Oncol
Publication date
2002
First author
Dearden CE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dearden CE
      type
      Author
    2. name
      Matutes E
      type
      Author
    3. name
      Catovsky D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dearden CE
      type
      Author
    2. name
      Matutes E
      type
      Author
    3. name
      Catovsky D
      type
      Author
    bibliography ids
    1. nci-bib-6cd6bb3166a7f4940519184b
    book metadata
    content sha256
    6b23a342e04dcc0e8e02e41c7a9021b4c223e4ab1f3cf2fdca7e2558fb7c8abe
    document type
    citation
    dois
    1. 10.1385/mo:19:2s:s27
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:12180489
    immutable id
    pubmed:12180489@6b23a342e04dcc0e8e02e41c7a9021b4c223e4ab1f3cf2fdca7e2558fb7c8abe
    journal
    abbreviation
    Med Oncol
    issn electronic
    Source null
    issn print
    1357-0560
    issue
    Source null
    name
    Medical oncology (Northwood, London, England)
    nlm unique id
    9435512
    pages
    S27-32
    volume
    19 Suppl
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      12180489
      provenance
      batch id
      ced7794d3512d3f45188
      provider
      NCBI PubMed ESummary
      record sha256
      7bc969844446c419c0add368797d607d5d144a96b9d92792ab4c92553176b8f9
      response sha256
      782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
      retrieved at
      2026-09-09T23:45:46.208577+00:00
      publication date
      display
      2002
      precision
      year
      year
      2002
      publication types
      1. Journal Article
      2. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/12180489/
      title
      Alemtuzumab in T-cell malignancies.

      Preserved source evidence · Independent clinical review pending · Not medical advice